Vimta Labs Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹548.25
- Today's High:
- ₹580.95
- Open Price:
- ₹572
- 52W Low:
- ₹287.508
- 52W High:
- ₹621.4
- Prev. Close:
- ₹566.05
- Volume:
- 6992
Company Statistics
- Market Cap.:
- ₹0
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Vimta Labs Limited had its IPO on under the ticker symbol 524394.
The company operates in the Other sector and Other industry. Vimta Labs Limited has a staff strength of 0 employees.
Stock update
Shares of Vimta Labs Limited opened at ₹572 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹548.25 - ₹580.95, and closed at ₹554.4.
This is a -2.06% slip from the previous day's closing price.
A total volume of 6,992 shares were traded at the close of the day’s session.
In the last one week, shares of Vimta Labs Limited have slipped by -4.53%.
Vimta Labs Limited's Key Ratios
Vimta Labs Limited has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Vimta Labs Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Vimta Labs Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vimta Labs Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Vimta Labs Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Vimta Labs Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vimta Labs Limited’s profitability.
Vimta Labs Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Vimta Labs Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹3.62 billion
- Total Liabilities
- ₹572.77 million
- Operating Cash Flow
- ₹-572560000.00
- Capital Expenditure
- ₹498.05 million
- Dividend Payout Ratio
- 0%
Vimta Labs Limited ended 2024 with ₹3.62 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹3.62 billion while shareholder equity stood at ₹2.82 billion.
Vimta Labs Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹572.77 million in other current liabilities, 44260000.00 in common stock, ₹2.77 billion in retained earnings and ₹55.80 million in goodwill. Its cash balance stood at ₹92.77 million and cash and short-term investments were ₹408.22 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹98.91 million.
Vimta Labs Limited’s total current assets stands at ₹1.64 billion while long-term investments were ₹0 and short-term investments were ₹10.45 million. Its net receivables were ₹799.86 million compared to accounts payable of ₹144.39 million and inventory worth ₹226.22 million.
In 2024, Vimta Labs Limited's operating cash flow was ₹-572560000.00 while its capital expenditure stood at ₹498.05 million.
Comparatively, Vimta Labs Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹554.4
- 52-Week High
- ₹621.4
- 52-Week Low
- ₹287.508
- Analyst Target Price
- ₹
Vimta Labs Limited stock is currently trading at ₹554.4 per share. It touched a 52-week high of ₹621.4 and a 52-week low of ₹621.4. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹502.88 and 200-day moving average was ₹410.3 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Vimta Labs Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers analytical testing services for food and agriculture, and drugs and pharmaceutical products, as well as tests water samples for various purposes and specifications. Its environmental assessment services comprise site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; and industrial emission source monitoring services. The company?s environmental assessment services also include offshore sampling and analysis of marine water and sediments, marine ecological studies, marine impact assessment, rehabilitation and resettlement studies, forestry and ecological studies, geo-technical studies, geological and hydro-geological studies, land use/land cover studies based on remote sensing, socio-economic and due diligence studies, epidemiological studies, wasteland management studies, and study on bio-indicators. In addition, it offers clinical research services, such as phase-I/bioequivalence studies, as well as screening and recruitment services; conducts studies on various dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, solutions, transdermal patches, injectables, etc.; and offers regulatory audit history services. Further, the company offers clinical reference lab services; pre-clinical services to pharmaceutical, biotech, and medical device companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and biopharmaceutical services in the areas of genomics and proteomics. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.